The observed effects in animal models suggest that MC4R agonists could be valuable as neuroprotective and neurodegenerative agents in various neurodegenerative diseases, addressing a significant unmet medical need, such as in multiple sclerosis (MS). The gene discussed is MC4R; the disease is neurodegenerative disease.